DB
AUPH icon

Danske Bank’s Aurinia Pharmaceuticals AUPH Stock Holding History

Danske Bank’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.09K Hold
300
– – ﹤0.01% 922
2026
Q1 		$4.45K Sell
300
-3,300
-92% -$48.2K ﹤0.01% 925
2025
Q4 		$57.4K Sell
3,600
-72,820
-95% -$1.03M ﹤0.01% 946
2025
Q3 		$844K Sell
76,420
-21,823
-22% -$238K ﹤0.01% 712
2025
Q2 		$832K Buy
+98,243
New +$788K ﹤0.01% 733

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Danske Bank's AUPH Position: Q2 2026 in Review

Danske Bank held its Aurinia Pharmaceuticals (AUPH) position steady in Q2 2026 at 300 shares worth $5.09K. The position accounts for ﹤0.01% of the portfolio, ranked #922.

Danske Bank first reported a position in AUPH in Q2 2025 and has held it in 5 quarters since. The position peaked at $844K in Q3 2025. 282 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • Danske Bank held 300 shares of Aurinia Pharmaceuticals worth $5.09K as of Q2 2026.
  • Danske Bank left its Aurinia Pharmaceuticals share count unchanged in Q2 2026.
  • Aurinia Pharmaceuticals made up ﹤0.01% of Danske Bank's portfolio in Q2 2026, its #922 holding.
  • Danske Bank first reported a position in Aurinia Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • Danske Bank's Aurinia Pharmaceuticals position peaked at $844K in Q3 2025.
  • 282 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.